Biologics Mixing, Diluting, and Repackaging: FDA Draft Guidance
Bio Relief: US FDA Rules On Biosimilars Naming
The suspense is over: the US Food and Drug Administration (FDA) has made their decision.
What President Trump Means for Big Pharma
Patients may save money on prescriptions---and cut down pharma's profits.
Mylan and Momenta Pharma Combine Biosimilar Forces
Mylan and Momenta Pharmaceuticals to develop, manufacture, and commercialize six of Momenta’s current biosimilar candidates.
FDA Finalizes Biosimilar Guidance
Was waiting the worst part?
Breaking News: Supreme Court Declines to Hear 'Patent Dance' Case
July federal appeals court ruling will not be heard.
2 Commerce Drive Cranbury, NJ 08512